Abstract
As part of the intensive efforts in facilitating drug discovery, computational methods have been explored as low-cost and efficient tools for predicting various toxicological properties and adverse drug reactions (ADR) of pharmaceutical agents. More recently, machine learning methods have been applied for developing tools capable of predicting diverse spectrum of compounds of different toxicological properties and ADR profiles. Based on the results of a number of studies, these methods have shown promising potential in predicting a variety of toxicological properties and ADR profiles. This article reviews the strategies, current progresses, underlying difficulties and future prospects in using machine learning methods for predicting compounds of specific toxicological property or ADR profile.
Keywords: Statistical learning methods, toxicology, molecular descriptors, structural diversity, adverse effects, risk assessment, drug design, pharmaceutical preparations
Current Drug Safety
Title: Advances in Machine Learning Prediction of Toxicological Properties and Adverse Drug Reactions of Pharmaceutical Agents
Volume: 3 Issue: 2
Author(s): Xiao Hua Ma, Rong Wang, Yin Xue, Ze Rong Li, Sheng Yong Yang, Yu Quan Wei and Yu Zong Chen
Affiliation:
Keywords: Statistical learning methods, toxicology, molecular descriptors, structural diversity, adverse effects, risk assessment, drug design, pharmaceutical preparations
Abstract: As part of the intensive efforts in facilitating drug discovery, computational methods have been explored as low-cost and efficient tools for predicting various toxicological properties and adverse drug reactions (ADR) of pharmaceutical agents. More recently, machine learning methods have been applied for developing tools capable of predicting diverse spectrum of compounds of different toxicological properties and ADR profiles. Based on the results of a number of studies, these methods have shown promising potential in predicting a variety of toxicological properties and ADR profiles. This article reviews the strategies, current progresses, underlying difficulties and future prospects in using machine learning methods for predicting compounds of specific toxicological property or ADR profile.
Export Options
About this article
Cite this article as:
Ma Hua Xiao, Wang Rong, Xue Yin, Li Rong Ze, Yang Yong Sheng, Wei Quan Yu and Chen Zong Yu, Advances in Machine Learning Prediction of Toxicological Properties and Adverse Drug Reactions of Pharmaceutical Agents, Current Drug Safety 2008; 3 (2) . https://dx.doi.org/10.2174/157488608784529224
DOI https://dx.doi.org/10.2174/157488608784529224 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
CT Image Reconstruction Using NLMfuzzyCD Regularization Method
Current Medical Imaging Lacticin LC14, a New Bacteriocin Produced by Lactococcus lactis BMG6.14: Isolation, Purification and Partial Characterization
Infectious Disorders - Drug Targets Life Under Stress: The Probiotic Stress Response and How it may be Manipulated
Current Pharmaceutical Design TDAE-Initiated Synthesis of Oxiranes in Heterocyclic Series: Reaction of 2-(Dibromomethyl)quinoxaline with α-Dicarbonyl Derivatives
Letters in Organic Chemistry Namitecan: a Hydrophilic Camptothecin with a Promising Preclinical Profile
Current Medicinal Chemistry Pharmacogenomics of Human ABC Transporters: Detection of Clinically Important SNPs by SmartAmp2 Method
Current Pharmaceutical Biotechnology Development of Peptide and Protein Based Radiopharmaceuticals
Current Pharmaceutical Design Classical to Current Approach for Treatment of Psoriasis: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Current Therapeutic Approaches in Inflammatory Bowel Disease
Current Pharmaceutical Design Design and In vitro Validation of Multivalent Dendrimer Methotrexates as a Folate-targeting Anticancer Therapeutic
Current Pharmaceutical Design Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site
Anti-Cancer Agents in Medicinal Chemistry The Impact of Natural Compounds on the Treatment of Neurodegenerative Diseases
Current Organic Chemistry Synthesis and Biological Activity of 3-(substitutedphenyl)- 6-(4-methoxyphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) One-pot Synthesis of Dihydropyrano[2,3-c]chromenes via a Three-component Reaction in Aqueous Media
Combinatorial Chemistry & High Throughput Screening The Challenges Involved in Modeling Toxicity Data In Silico: A Review
Current Pharmaceutical Design A Review on Recent Patents and Applications of Inorganic Material Binding Peptides
Recent Patents on Nanotechnology The Anti-Inflammatory and Pharmacological Actions of Oleocanthal, a Phenolic Contained in Extra Virgin Olive Oil
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Innovative Anthocyanin/Anthocyanidin Formulation Protects SK-N-SH Cells Against the Amyloid-β Peptide-Induced Toxicity: Relevance to Alzheimer’s Disease
Central Nervous System Agents in Medicinal Chemistry Quantification of Hypocrellin B in Rabbit Ocular Tissues/Plasma by Spectrofluorimeter: Application to Biodistribution Study
Current Bioactive Compounds Effectiveness and Tolerability of Very-low Volume Preparation for Colonoscopy: A Narrative Review
Current Drug Metabolism